The Davis Lab at Penn Neurology researches new approaches in invasive neurophysiology and neuroimaging for refractory epilepsy.
Clinicians at Penn Hematology Oncology are using innovative approaches for older adults ineligible for first-line therapy for acute myeloid leukemia.
The Penn Functional Radiation Medicine program is investigating low-dose radiation therapy as a treatment for osteoarthritis of the hip and knee.
As Penn Medicine researchers drive innovation forward, advances in treatment are transforming melanoma into a model for scientific breakthrough.
Basser Center for BRCA genetic counselors integrate research and clinical practice to guide providers in genetic testing for high-risk patients.
Article abstracts from the summer 2026 issue of the Journal of Lancaster General Hospital. Topics include sports, trauma, and diabetes medicine.
A less intense form of this mainstay of cancer treatment is now being applied to other conditions.
The Abramson Cancer Center’s legacy of holistic care is the foundation for cancer care and research that aims to become a model for the world.
A new initiative frees Penn primary care doctors from most on-call duties after work hours, while patients still have 24-hour access to virtual care.
